Adverse effects of CXCL12 on ovarian cancer also may be due to effects on the stromal compartment of the tumor microenvironment, including enhanced angiogenesis and recruitment of immunosuppressive cells [8], [9], [10], [11]. Here, CXCL12 is linked to ovarian carcinoma.